ERAS vs SON

Comparison between Erasca Inc (ERAS, Company) and Sonoco Products Company (SON, Company).

ERAS is from the Healthcare sector, while SON is from the Consumer Cyclical sector.

5-Year PerformanceERAS has outperformed SON, delivering a return of +1.1% compared to +0.3%

ERAS vs SON - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ERAS(COMPANY)	SON(COMPANY)
Market Cap	$5.57B	$5.55B
Max Drawdown	95.65%	62.24%
Sharpe Ratio	2.97	0.80
5Y Beta	1.37	0.60
Industry	Biotechnology	Packaging & Containers
P/E Ratio	-19.48	5.45
Forward P/E	N/A	10.29
PEG Ratio	-0.31	0.01
Dividend Yield	N/A	3.69%
5Y Dividends CAGR	N/A	8.61%
5Y EPS CAGR	N/A	31.39%
Debt to Equity	0.00%	131.41%
Free Cash Flow Yield	-1.64%	3.90%
P/S Ratio	N/A	0.74
P/B Ratio	14.16	1.56

Market Cap

Winner

ERAS

$5.57B

SON

$5.55B

Max Drawdown

ERAS

95.65%

Winner

SON

62.24%

Sharpe Ratio

Winner

ERAS

2.97

SON

0.80

5Y Beta

ERAS

1.37

Winner

SON

0.60

Industry

ERAS

Biotechnology

SON

Packaging & Containers

P/E Ratio

Winner

ERAS

-19.48

SON

5.45

Forward P/E

ERAS

N/A

SON

10.29

PEG Ratio

Winner

ERAS

-0.31

SON

0.01

Dividend Yield

ERAS

N/A

SON

3.69%

5Y Dividends CAGR

ERAS

N/A

SON

8.61%

5Y EPS CAGR

ERAS

N/A

SON

31.39%

Debt to Equity

Winner

ERAS

0.00%

SON

131.41%

Free Cash Flow Yield

ERAS

-1.64%

Winner

SON

3.90%

P/S Ratio

ERAS

N/A

SON

0.74

P/B Ratio

ERAS

14.16

Winner

SON

1.56

ERAS vs SON - Historical Returns

Returns include dividend reinvestment.

Period	ERAS	SON
1 month	+42.66%	+18.65%
3 months	+7.62%	+5.59%
6 months	+255.13%	+26.06%
1 year	+1192.96%	+27.42%
5 years(CAGR)	+1.05%	+0.26%
10 years(CAGR)	N/A	+4.72%
Max(CAGR)	+1.05%	+6.89%

Winner

ERAS

+42.66%

SON

+18.65%

Winner

ERAS

+7.62%

SON

+5.59%

Winner

ERAS

+255.13%

SON

+26.06%

Winner

ERAS

+1192.96%

SON

+27.42%

5Y(CAGR)

Winner

ERAS

+1.05%

SON

+0.26%

10Y(CAGR)

ERAS

N/A

SON

+4.72%

Max(CAGR)

ERAS

+1.05%

Winner

SON

+6.89%

ERAS vs SON - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	ERAS	SON
2026	+411.42%	+29.87%
2025	+37.78%	-4.68%
2024	+15.67%	-10.91%
2023	-50.00%	-4.04%
2022	-72.16%	+9.07%
2021	-10.61%	+1.99%
2020	N/A	+0.61%
2019	N/A	+21.51%
2018	N/A	+1.65%
2017	N/A	+2.69%
2016	N/A	+34.99%
2015	N/A	-3.00%
2014	N/A	+8.26%
2013	N/A	+42.21%
2012	N/A	-6.86%
2011	N/A	-1.39%
2010	N/A	+16.04%
2009	N/A	+27.11%
2008	N/A	-26.85%
2007	N/A	-12.64%
2006	N/A	+33.93%
2005	N/A	+3.89%
2004	N/A	+24.79%
2003	N/A	+9.93%
2002	N/A	-9.98%
2001	N/A	+28.88%
2000	N/A	+2.83%
1999	N/A	-4.25%

ERAS vs SON Drawdown Comparison

The maximum drawdown for ERAS was -95.65%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The maximum drawdown for SON was -59.58%, occurring on Mar 9, 2009. Recovery took 1535 trading sessions.

The current ERAS drawdown is -24.57%. The current SON drawdown is -1.62%.

Rank	ERAS	SON
#1	-95.65% Sep 2, 2021 - Apr 8, 2025	-59.58% Jun 4, 2007 - Jul 9, 2013
#2	-8.89% Aug 9, 2021 - Aug 25, 2021	-41.55% Jul 5, 2019 - Mar 8, 2021
#3	-8.19% Jul 30, 2021 - Aug 9, 2021	-33.64% May 17, 2021 - Jul 2, 2026
#4	-5.75% Jul 22, 2021 - Jul 29, 2021	-32.23% Apr 10, 2002 - Nov 4, 2004
#5	-4.39% Aug 31, 2021 - Sep 2, 2021	-30.66% Nov 16, 1999 - Jan 29, 2001
#6	N/A	-21.71% Sep 4, 2001 - Dec 21, 2001
#7	N/A	-19.76% Feb 26, 2015 - Mar 9, 2016
#8	N/A	-19.39% Jan 30, 2001 - May 16, 2001
#9	N/A	-15.29% Dec 4, 2017 - Jul 19, 2018
#10	N/A	-14.45% Jul 1, 2014 - Dec 11, 2014
#11	N/A	-13.70% Mar 4, 2005 - Dec 2, 2005
#12	N/A	-13.25% Apr 6, 2006 - Sep 12, 2006
#13	N/A	-13.20% Dec 3, 2018 - Feb 5, 2019
#14	N/A	-13.00% Dec 30, 2004 - Mar 1, 2005
#15	N/A	-12.72% Nov 29, 2016 - Dec 1, 2017